ENDRA Life Sciences (NDRA) Gross Margin (2016 - 2018)

ENDRA Life Sciences (NDRA) has 3 years of Gross Margin data on file, last reported at 100.0% in Q1 2018.

• Gross Margin for Q1 2018 came in at 100.0%, changed N/A year-over-year; the trailing twelve-month figure through Dec 2018 was 100.0% (up 4914.0% YoY), and the FY2018 annual result was 100.0%, up 4914.0% from the prior year.
• Gross Margin grew to 100.0% in Q1 2018 per NDRA's latest filing, from 54.96% in the prior quarter.
• Over five years, Gross Margin peaked at 100.0% in Q1 2018 and troughed at 10.98% in Q2 2017.
• A 3-year average of 55.8% and a median of 54.96% in 2017 frame the typical range for Gross Margin.
• On a YoY basis, Gross Margin climbed as much as 71 bps in 2017 and fell as far as 71 bps in 2017.
• A 3-year view of Gross Margin shows it stood at 54.25% in 2016, then grew by 1 bps to 54.96% in 2017, then surged by 82 bps to 100.0% in 2018.
• Business Quant data shows NDRA's Gross Margin at 100.0% in Q1 2018, 54.96% in Q4 2017, and 58.79% in Q3 2017.